Correlation of polypeptide N-acetylgalactosamine transferases-3 and -6 to different stages of endometriosis

article OA: closed CC0 ⤵ 1 in-corpus citation
AI-generated summary by gemini-2.5-flash-lite+body, 2026-06-13

This study found that N-acetylgalactosamine transferases-3 and -6 expression was lower in ectopic endometrium and significantly correlated with endometriosis stages.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text

This study investigated expression patterns of polypeptide N-acetylgalactosamine transferases GalNAc-T3 and GalNAc-T6 in clinicopathologically characterized endometriosis by comparing ectopic and eutopic endometrial tissues from women with EMS (n=12) to control endometrium from women undergoing uterine septum surgery (n=12). Using qRT-PCR, immunohistochemistry, and western blotting (with CD-10 confirmed tissue identity), the authors found that both GalNAc-T3 and GalNAc-T6 were expressed in all groups without significant menstrual-cycle–related changes, but were significantly lower in ectopic endometrium than in eutopic and control endometrium, with no significant eutopic versus control differences. Expression of both enzymes was also significantly lower in stage III/IV EMS compared with stage I/II. The paper’s caveat is the small sample size (12 per group), which may limit generalizability. This paper is centrally about endometriosis—specifically altered GalNAc-T3 and GalNAc-T6 expression across ectopic versus eutopic tissue and across endometriosis stages.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PurposeTo investigate the expression patterns of N-acetyl galactosamine transferases (GalNAc-Ts)-3 and GalNAc-T6 in clinicopathologically characterized endometriosis (EMS), and to explore their clinical significance.MethodsEctopic and eutopic endometrial tissue samples were obtained and confirmed with CD-10 immunohistochemistry in patients with EMS (n = 12), whereas normal control endometrium was obtained from patients with uterine septum (n = 12). The mRNA and protein levels of GalNAc-T3 and GalNAc-T6 were detected in these samples using quantitative real-time PCR, immunohistochemistry, and western blotting.ResultsGalNAc-T3 and GalNAc-T6 were expressed in the endometrium of all groups, with no significant changes observed during the menstrual cycle. The expression of GalNAc-T3 and GalNAc-T6 in ectopic endometrium was significantly lower than that in eutopic (P < 0.05) or control endometrium (P  0.05) between eutopic and control endometria. Furthermore, the expression of GalNAc-T3 and GalNAc-T6 was significantly lower in patients with stage III/IV EMS compared to patients with stage I/II (P < 0.05).ConclusionsBoth GalNAc-T3 and GalNAc-T6 expression levels were downregulated in ectopic endometrium, which may increase the adhesion and invasion of endometrial cells and contribute to the development of EMS. Moreover, we found a strong correlation between the expression of GalNAc-T3 and GalNAc-T6 and different stages of EMS.
Full text 10,035 characters · extracted from oa-doi-fallback · 6 sections · click to expand

Abstract

Purpose To investigate the expression patterns of N-acetyl galactosamine transferases (GalNAc-Ts)-3 and GalNAc-T6 in clinicopathologically characterized endometriosis (EMS), and to explore their clinical significance.

Methods

Ectopic and eutopic endometrial tissue samples were obtained and confirmed with CD-10 immunohistochemistry in patients with EMS (n = 12), whereas normal control endometrium was obtained from patients with uterine septum (n = 12). The mRNA and protein levels of GalNAc-T3 and GalNAc-T6 were detected in these samples using quantitative real-time PCR, immunohistochemistry, and western blotting.

Results

GalNAc-T3 and GalNAc-T6 were expressed in the endometrium of all groups, with no significant changes observed during the menstrual cycle. The expression of GalNAc-T3 and GalNAc-T6 in ectopic endometrium was significantly lower than that in eutopic (P < 0.05) or control endometrium (P 0.05) between eutopic and control endometria. Furthermore, the expression of GalNAc-T3 and GalNAc-T6 was significantly lower in patients with stage III/IV EMS compared to patients with stage I/II (P < 0.05).

Conclusions

Both GalNAc-T3 and GalNAc-T6 expression levels were downregulated in ectopic endometrium, which may increase the adhesion and invasion of endometrial cells and contribute to the development of EMS. Moreover, we found a strong correlation between the expression of GalNAc-T3 and GalNAc-T6 and different stages of EMS. Similar content being viewed by others

References

Nassif J, Trompoukis P, Barata S, Furtado A, Gabriel B, Wattiez A (2011) Management of deep endometriosis. Reprod Biomed Online 23:25–33. doi:10.1016/j.rbmo.2010.08.012 Gordts S, Puttemans P, Gordts S, Valkenburg M, Brosens I, Campo R (2014) Transvaginal endoscopy and small ovarian endometriomas: unravelling the missing link? Gynecol Surg 11:3–7. doi:10.1007/s10397-013-0817-1 Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D’Hooghe T (2009) High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril 92:68–74. doi:10.1016/j.fertnstert.2008.04.056 Eskenazi B, Warner M, Bonsignore L, Olive D, Samuels S, Vercellini P (2001) Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril 76:929–935. doi:10.1016/S0015-0282(01)02736-4 Saba L, Sulcis R, Melis GB, Ibba G, Alcazar JL, Piga M, Guerriero S (2014) Diagnostic confidence analysis in the magnetic resonance imaging of ovarian and deep endometriosis: comparison with surgical results. Eur Radiol 24:335–343. doi:10.1007/s00330-013-3013-9 Gargett CE, Schwab KE, Brosens JJ, Puttemans P, Benagiano G, Brosens I (2014) Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis. Mol Hum Reprod 20:591–598. doi:10.1093/molehr/gau025 Kobayashi H, Uekuri C, Shigetomi H (2014) Towards an understanding of the molecular mechanism of endometriosis: unbalancing epithelial-stromal genetic conflict. Gynecol Endocrinol 30:7–15. doi:10.3109/09513590.2013.831832 Marie E., Sutherlin INTC, Takeshi Iwamura HCAM (1997) Expression of Three UDP-N-acetyl-a-d-galactosamine: polypeptide Ga1NAc N-Acetylagalactosaminyltransferases in Adenocarcinoma Cell Lines 57: 4744–4748 Sprecher E (2010) Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification. J Invest Dermatol 130:652–660. doi:10.1038/jid.2009.337 Ten Hagen KG (2003) All in the family: the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13:1R–16R. doi:10.1093/glycob/cwg007 Fritz TA, Raman J, Tabak LA (2006) Dynamic association between the catalytic and lectin domains of human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase-2. J Biol Chem 281:8613–8619. doi:10.1074/jbc.M513590200 Ishikawa M, Kitayama J, Kohno K, Nagawa H (2005) The expression pattern of UDP-N-acetyl-alpha-d-galactosamine-polypeptide N-acetyl-galactosaminyl transferase-3 in squamous cell carcinoma of the esophagus. Pathobiology 72:139–145. doi:10.1159/000084117 Inoue T, Tsuneyoshi M, Eguchi T, Oda Y, Nishiyama K, Fujii KIH, Kohno K, Yamaguchi K, Tanaka M (2007) Expression of GalNAc-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections-Special reference to its association with lymph node metastases. Modern Pathol 20:267–276 doi:10.1038/modpathol.3800700. Noel JC, Chapron C, Fayt I, Anaf V (2008) Lymph node involvement and lymphovascular invasion in deep infiltrating rectosigmoid endometriosis. Fertil Steril 89:1069–1072. doi:10.1016/j.fertnstert.2007.05.011 Anaf V, El NI, Simon P, Van de Stadt J, Fayt I, Simonart T, Noel JC (2004) Preferential infiltration of large bowel endometriosis along the nerves of the colon. Hum Repord 19:996–1002 doi:10.1093/humrep/deh150 Bulun SE (2009) Endometriosis. N Engl J Med 360:268–279. doi:10.1056/NEJMra0804690 Guo SW (2009) Recurrence of endometriosis and its control. Hum Reprod Update 15:441–461. doi:10.1093/humupd/dmp007 Kondo A, Li W, Nakagawa T, Nakano M, Koyama N, Wang X, Gu J, Miyoshi E, Taniguchi N (2006) From glycomics to functional glycomics of sugar chains: Identification of target proteins with functional changes using gene targeting mice and knock down cells of FUT8 as examples. Biochimica et Biophysica Acta (BBA) - Proteins Proteomics 1764:1881–1889. doi:10.1016/j.bbapap.2006.10.011 Bennett EP et al (1996) cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-d-galactosamine: 271(29):17006–17012 Wandall HH, Hassan H, Mirgorodskaya E, Kristensen AK, Roepstorff P, Bennett EP, Nielsen PA, Hollingsworth MA, Burchell J, Taylor-Papadimitriou J, Clausen H (1997) Substrate specificities of three members of the human UDP-N-acetyl-alpha-d-galactosamine: polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J Biol Chem 272:23503–23514 Gu C, Oyama T, Osaki T, Li J, Takenoyama M, Izumi H, Sugio K, Kohno K, Yasumoto K (2004) Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Br J Cancer 90:436–442. doi:10.1038/sj.bjc.6601531 Dosaka-Akita H, Kohno K, Kinoshita I, Yamazaki K, Izumi H, Itoh T, Katoh H, Nishimura M, Matsuo K, Yamada Y (2002) N-acetylgalactosaminyl transferase-3 is a potential new marker for non-small cell lung cancers. Brit. J Cancer 87:751–755. doi:10.1038/sj.bjc.6600536 Onitsuka K, Shibao K, Nakayama Y, Minagawa N, Hirata K, Izumi H, Matsuo K, Nagata N, Kitazato K, Kohno K, Itoh H (2003) Prognostic significance of UDP-N-acetyl-alpha-d-galactosamine:polypeptide N-acetylgalactosaminyltransferase-3 (GalNAc-T3) expression in patients with gastric carcinoma. Cancer Sci 94:32–36 Berois N, Mazal D, Ubillos L, Trajtenberg F, Nicolas A, Sastre-Garau X, Magdelenat H, Osinaga E (2006) UDP-N-Acetyl-d-Galactosamine: Polypeptide N-Acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker. J Histochem Cytochem 54:317–328. doi:10.1369/jhc.5A6783.2005 Park JH, Nishidate T, Kijima K, Ohashi T, Takegawa K, Fujikane T, Hirata K, Nakamura Y, Katagiri T (2010) Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. Cancer Res 70:2759–2769. doi:10.1158/0008-5472.CAN-09-3911 Bennett EP, Hassan H, Mandel U, Hollingsworth MA, Akisawa N, Ikematsu Y, Merkx G, van Kessel AG, Olofsson S, Clausen H (1999) Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-d-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy. J Biol Chem 274:25362–25370 Kitada S, Yamada S, Kuma A, Ouchi S, Tasaki T, Nabeshima A, Noguchi H, Wang KY, Shimajiri S, Nakano R, Izumi H, Kohno K, Matsumoto T, Sasaguri Y (2013) Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas. Br J Cancer 109:472–481. doi:10.1038/bjc.2013.331 Li Z, Yamada S, Inenaga S, Imamura T, Wu Y, Wang KY, Shimajiri S, Nakano R, Izumi H, Kohno K, Sasaguri Y (2011) Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival. Br J Cancer 104:1882–1889. doi:10.1038/bjc.2011.166 Wang ZQ, Bachvarova M, Morin C, Plante M, Gregoire J, Renaud MC, Sebastianelli A, Bachvarov D (2014) Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation. Oncotarget 5:544–560

Acknowledgements

The authors thank the women who participated in our study. The authors also wish to acknowledge the contribution of colleagues and the support of Women’s Hospital, Zhejiang University School of Medicine. Authors’ contributions XX: Project development, Data Collection, Manuscript writing, XF: Data collection, Data analysis, Manuscript writing, JM: Project development, QY: Data collection or management, CZ: Immunohistochemical experiment, KX: Project development, LJ: Project development, Manuscript editing. Author information Authors and Affiliations Corresponding authors Ethics declarations Conflict of interest The authors declare that they have no conflict of interest. Informed consent Informed consent was obtained from all individual participants included in the study. Additional information X. Xu and X. Fei contributed equally to this study and should be considered co-first authors. Rights and permissions About this article Cite this article Xu, X., Fei, X., Ma, J. et al. Correlation of polypeptide N-acetylgalactosamine transferases-3 and -6 to different stages of endometriosis. Arch Gynecol Obstet 295, 1413–1419 (2017). https://doi.org/10.1007/s00404-017-4344-6 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-017-4344-6

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometrium N-Acetylgalactosaminyltransferases Adult Blotting, Western Endometriosis Endometriosis Endometrium Female Humans Immunohistochemistry Menstrual Cycle Menstrual Cycle Middle Aged N-Acetylgalactosaminyltransferases Polypeptide N-acetylgalactosaminyltransferase Real-Time Polymerase Chain Reaction RNA, Messenger RNA, Messenger

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Cited by (1)

Source provenance

europepmc
last seen: 2026-08-25T06:10:03.373225+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:31.759405+00:00
License: CC0 · commercial use OK